{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T13:10:01Z","timestamp":1739711401525,"version":"3.37.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.euroneuro.2009.11.012","type":"journal-article","created":{"date-parts":[[2009,12,31]],"date-time":"2009-12-31T09:07:52Z","timestamp":1262250472000},"page":"218-225","source":"Crossref","is-referenced-by-count":3,"title":["(+)-UH 232, a partial agonist of the D3 dopamine receptors, attenuates cognitive effects of angiotensin IV and des-Phe6-angiotensin IV in rats"],"prefix":"10.1016","volume":"20","author":[{"given":"Jan J.","family":"Braszko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2009.11.012_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3758\/BF03335453","article-title":"Retention of a passive avoidance responses as a function of the intensity and duration of electric shock","volume":"26","author":"Ader","year":"1972","journal-title":"Psychon. Sci."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib2","doi-asserted-by":"crossref","first-page":"48623","DOI":"10.1074\/jbc.C100512200","article-title":"Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin-regulated aminopeptidase","volume":"276","author":"Albiston","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib3","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.pnpbp.2005.04.020","article-title":"Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat","volume":"29","author":"Barik","year":"2005","journal-title":"Prog. Neuro-Psychopharm. Biol. Psychiatr."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib4","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.peptides.2004.04.014","article-title":"Involvement of D1 dopamine receptors in the cognitive effects of angiotensin IV and des-Phe6 angiotensin IV","volume":"25","author":"Braszko","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.euroneuro.2009.11.012_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.physbeh.2006.03.025","article-title":"D2 dopamine receptor blockade prevents cognitive effects of Ang IV and des-Phe6-Ang IV","volume":"88","author":"Braszko","year":"2006","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.euroneuro.2008.08.011","article-title":"Dopamine D4 receptor antagonist L745, 870 abolishes cognitive effects of intracerebroventricular angiotensin IV and des-Phe6-Ang IV in rats","volume":"19","author":"Braszko","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3317\/jraas.2006.027","article-title":"Cognitive effects attributed to angiotensin II may result from its conversion to angiotensin IV","volume":"7","author":"Braszko","year":"2006","journal-title":"J. Renin. Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.npep.2008.02.001","article-title":"Effect of D3 dopamine receptors blockade on the cognitive effects of angiotensin IV in rats","volume":"42","author":"Braszko","year":"2008","journal-title":"Neuropeptides"},{"key":"10.1016\/j.euroneuro.2009.11.012_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0166-4328(87)90068-4","article-title":"Psychotropic effects of angiotensin II and III in rats: locomotor and exploratory vs. cognitive behaviour","volume":"25","author":"Braszko","year":"1987","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.pharmtox.41.1.237","article-title":"Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence","volume":"41","author":"Carlsson","year":"2001","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib11","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1523\/JNEUROSCI.4712-05.2006","article-title":"Dopamine D3 receptors regulate GABAA receptor function through a phospho-dependent endocytosis mechanism in nucleus accumbens","volume":"26","author":"Chen","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bcp.2004.05.047","article-title":"Endogenous cystinyl aminopeptidase in Chinese hamster ovary cells: characterization by [125I]Ang IV binding and catalytic activity","volume":"68","author":"Demaegdt","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1034\/j.1600-0404.2003.00098.x","article-title":"Arterial hypertension and ischaemic stroke","volume":"107","author":"Droste","year":"2003","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib14","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1111\/j.1460-9568.2005.04438.x","article-title":"Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons","volume":"22","author":"Du","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0166-4328(05)80315-8","article-title":"A new one-trial test for neurobiological studies of memory in rats. III. Spatial vs nonspatial working memory","volume":"51","author":"Ennaceur","year":"1992","journal-title":"Behav. Brain. Res."},{"issue":"Suppl 2","key":"10.1016\/j.euroneuro.2009.11.012_bib16","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1186\/1471-2202-9-S2-S15","article-title":"Cognitive-enhancing effects of angiotensin IV","volume":"9","author":"Gard","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"doi-asserted-by":"crossref","unstructured":"Gavras, H., Brunner, HR. (2001) Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure. Hypertension 37, 342\u2013345.","key":"10.1016\/j.euroneuro.2009.11.012_bib18","DOI":"10.1161\/01.HYP.37.2.342"},{"key":"10.1016\/j.euroneuro.2009.11.012_bib19","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/0014-2999(95)00460-3","article-title":"The preferential dopamine D3 receptor ligand, (+)-UH 232, is a partial agonist","volume":"282","author":"Griffon","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0006-8993(10)80047-2","article-title":"Identification of an AII(3\u20138) [AIV] binding site in guinea pig hippocampus","volume":"583","author":"Harding","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib21","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1523\/JNEUROSCI.3786-05.2006","article-title":"The dopamine D3 receptor is part of a homeostatic pathway regulating ethanol consumption","volume":"26","author":"Jeanblanc","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0006-8993(79)90184-7","article-title":"The behavioural effects of D-amphetamine are correlated with its effects on cAMP in different brain regions","volume":"168","author":"Kennedy","year":"1979","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:THRO.0000011379.68077.64","article-title":"Effects of angiotensin converting enzyme inhibitors on thrombotic mediators: potential clinical implications","volume":"15","author":"Kothari","year":"2003","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.euroneuro.2009.11.012_bib24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s007020050091","article-title":"Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia","volume":"105","author":"Lahti","year":"1998","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib25","doi-asserted-by":"crossref","first-page":"23107","DOI":"10.1074\/jbc.C200201200","article-title":"Angiotenisin IV is a potent agonist for constitutive active human AT1 receptors: distinct roles of the N- and C-terminal residues of angiotensin II during AT1 receptor activation","volume":"277","author":"Le","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bjp.0706866","article-title":"Assays for enhanced activity of low efficacy partial agonists at the D2 dopamine receptor","volume":"149","author":"Lin","year":"2006","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib27","doi-asserted-by":"crossref","first-page":"28511","DOI":"10.1074\/jbc.270.48.28511","article-title":"Interaction of Phe8 of angiotensin II with Lys199 anf His256 of AT1 receptor in agonist activation","volume":"270","author":"Noda","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J. Neurosci. Meth."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-3956(74)90062-4","article-title":"Pharmacology and physiology of stereotyped behaviour","volume":"11","author":"Randrup","year":"1974","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0196-9781(93)90071-N","article-title":"AT4 receptor binding characteristics: D-amino acid- and glycine-substituted peptides","volume":"14","author":"Sardinia","year":"1993","journal-title":"Peptides"},{"key":"10.1016\/j.euroneuro.2009.11.012_bib31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11886-001-0074-1","article-title":"The role of angiotensin-converting enzyme inhibitors in the treatment of hypertension","volume":"3","author":"Sleight","year":"2001","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2009.11.012_bib33","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1471-4159.2004.02600.x","article-title":"Metabolism of angiotensin II is required for its in vivo effect of dopamine release in the striatum of the rat","volume":"90","author":"Stragier","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.brainres.2006.11.010","article-title":"Involvement of insulin-regulated aminopeptidase and\/or aminopeptidase N in the angiotensin IV-induced effect on dopamine release in the striatum of the rat","volume":"1131","author":"Stragier","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib35","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1460-9568.2005.04188.x","article-title":"In vivo characterization of the angiotensin-(1-7)-induced dopamine and \u03b3-aminobutyric acid release in the striatum of the rat","volume":"22","author":"Stragier","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib36","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.tips.2008.03.009","article-title":"Antipsychotic drug action: antagonism, inverse agonism or partial agonism","volume":"29","author":"Strange","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF00508777","article-title":"(+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists","volume":"334","author":"Svensson","year":"1986","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pneurobio.2007.10.009","article-title":"Angiotensin receptor subtype mediated physiologies and behaviours: new discoveries and clinical targets","volume":"84","author":"Wright","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.euroneuro.2009.11.012_bib39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neuroscience.2005.07.054","article-title":"A possible role for dopamine D3 receptor stimulation in the induction of neurogenesis in the adult rat substantia nigra","volume":"136","author":"Van Kampen","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2009.11.012_bib40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000080958","article-title":"Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients","volume":"50","author":"Vogel","year":"2004","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2009.11.012_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00213-004-1858-y","article-title":"Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats","volume":"176","author":"Xi","year":"2004","journal-title":"Psychopharmacology"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X09002776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X09002776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T12:29:50Z","timestamp":1739708990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X09002776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0924977X09002776"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2009.11.012","relation":{},"ISSN":["0924-977X"],"issn-type":[{"type":"print","value":"0924-977X"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}